From *The Abraham and Sonia Rochlin IBD Unit, Department of Gastroenterology and Liver Diseases, Emek Medical Center, Afula, Israel

†The Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel

the ‡Pediatric Gastroenterology Unit, Emek Medical Center, Afula, Israel

the §Faculty of Medicine, Technion, Haifa, Israel.

Received March 20, 2023; accepted August 7, 2023.

Dr Zittan has received research support and consulting fees from Janssen, AbbVie, Takeda, Neopharm, Celgene, and Pfizer. The remaining authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.jpgn.org).

Address correspondence and reprint requests to Yotam Elimeleh, MD, The Abraham and Sonia Rochlin IBD Unit, Department of Gastroenterology and Liver Diseases, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula, 1834111, Israel (e-mail: [email protected]).